Aethlon Medical, Inc. (AEMD)

Aethlon Medical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	5.56	14.65	17.19	9.92	9.62
Cash & Cash Equivalents	5.56	14.65	17.19	9.92	9.62
Cash Growth	-62.04%	-14.77%	73.31%	3.16%	150.43%
Receivables	0	0	0.13	0.15	0.21
Other Current Assets	0.66	0.44	0.84	0.28	0.22
Total Current Assets	6.23	15.09	18.16	10.35	10.04
Property, Plant & Equipment	1.9	2.3	1.14	0.2	0.28
Goodwill and Intangibles	0	0	0	0.06	0.06
Other Long-Term Assets	0.12	0.12	0.12	0.06	0.01
Total Long-Term Assets	2.02	2.42	1.26	0.32	0.35
Total Assets	8.25	17.51	19.42	10.67	10.39
Accounts Payable	1.32	0.65	0.66	0.46	0.4
Deferred Revenue	0	0	0.34	0.11	0.1
Other Current Liabilities	0.51	0.86	0.82	0.8	0.57
Total Current Liabilities	1.83	1.51	1.82	1.38	1.07
Long-Term Debt	0.65	0.94	0.6	0	0.04
Total Long-Term Liabilities	0.65	0.94	0.6	0	0.04
Total Liabilities	2.48	2.44	2.43	1.38	1.11
Total Debt	0.65	0.94	0.6	0	0.04
Debt Growth	-30.85%	55.96%	-	-	-95.58%
Retained Earnings	-154.57	-142.36	-130.33	-119.91	-112.03
Comprehensive Income	-0.01	-0.01	0	0	0
Shareholders' Equity	5.77	15.06	17.13	9.43	9.41
Net Cash / Debt	4.91	13.71	16.59	9.92	9.57
Net Cash / Debt Growth	-64.18%	-17.34%	67.24%	3.61%	232.68%
Net Cash Per Share	1.96	6.68	11.24	8.20	28.04
Working Capital	4.4	13.59	16.33	8.98	8.97
Book Value Per Share	2.29	7.33	11.61	7.80	27.55

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).